Navigation Links
Phlo Affiliate Names Director Of Marketing
Date:11/7/2007

JACKSONVILLE, Fla., Nov. 7 /PRNewswire-FirstCall/ -- An affiliate of Phlo Corporation (OTC: PHLC) (the "Company") announced today that it has hired Dan Reynolds as its Director of Marketing. Mr. Reynolds is a marketing and communications expert with nearly 30 years of experience in the United States and Canada. Mr. Reynolds will support the branding, marketing, and communications functions of the Company, headed by Rudy Prajza, Chief Marketing Officer.

Mr. Reynolds' professional experience includes work in over 14 industries such as food and beverages, financial services, hospitality, telecommunications, automobiles, health and beauty aids, and petroleum. His direct working experience includes such internationally-recognized organizations as Gillette, Subway, Sears, Royal Bank, BMW, Honda, the Government of Canada, Brita (water purifiers), and Petro-Canada, among others.

Mr. Reynolds has worked with a number of marketing communications companies including Saatchi & Saatchi, DMB&B, Foote, Cone & Belding, and MacLaren-McCann Advertising.

AQUISS(TM) features the Company's Instant Nano Hydration and Cell Armor technologies, providing instant, direct delivery of rehydration and cell- repair-and-protection payloads into the bloodstream beginning through the membranes of the mouth. These Instant Nano Hydration and Cell Armor technologies help provide sustained wellness necessary for life's performances and vigorous longevity. In addition, the Company's nano-encapsulation technology prevents the destruction of its active payloads in the stomach.

Phlo is a biotechnology company and a manufacturer and marketer of products (primarily liquids) containing patented and patent-pending biotechnologies. Phlo is focusing its technology generation and acquisition efforts on those technologies related to enhancing cognition and personal performance, reducing the effects of aging, and preventing or ameliorating cancer.

Certain statements made herein that are not historical constitute "forward-looking" statements within the meaning of the Private Litigation Reform Act of 1995 and may contain words such as "anticipate," "believe," "expect," "future," "may," "will," "should," "plan," "projected," "intend," and similar expressions to identify such forward-looking statements. Such statements are based on a number of assumptions and on information and estimates supplied to Phlo Corporation by sources currently available to it. Such assumptions and estimates are subject to uncertainties, contingencies, and other factors, many of which are beyond Phlo Corporation's control. Actual results may differ materially from the statements set forth above.


'/>"/>
SOURCE Phlo Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Phlo Affiliate Reports Expanded Coverage to Oregon Border
2. Phlo Affiliate Reports AQUISS to be Sold in 450 7-Eleven Stores
3. Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
4. Phlo Affiliate to Launch AQUISS(TM) on East Coast
5. KGI Names Kerry Howell Vice President for Advancement
6. Vical Names Andrew de Guttadauro Vice President, Corporate Development
7. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. CryoLife Names Philip Theodore as Vice President, General Counsel
10. Genstar Names Michael Hurt to Its Strategic Advisory Board
11. PPD Names Daniel Darazsdi as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... PA (PRWEB) , ... January 18, 2017 , ... ... operations again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency ... engaging panel discussions to examine vital clinical research issues such as trial performance ...
(Date:1/18/2017)... ... ... Thirty-six startup companies in University City and Center City have been awarded ... Development in 2016 as part of the Keystone Innovation Zone (KIZ) Tax Credit Program. ... represent the highest number of awards to the largest number of companies in the ...
(Date:1/18/2017)... Jan. 18, 2017  Caris Life Sciences, a ... Foundation, the largest private funder of pancreatic cancer ... evaluating the impact of immunotherapy in the treatment ... enrollment services to identify potential trial candidates based ... treating physicians and study investigators. The Lustgarten Foundation ...
(Date:1/17/2017)... ... January 17, 2017 , ... LGC Maine ... its VALIDATE® SP2 calibration verification / linearity test kit. VALIDATE® SP2 evaluates Albumin, ... VALIDATE® SP2 kit is prepared using the CLSI recommended “equal delta” method for ...
Breaking Biology Technology:
(Date:1/13/2017)... N.Y. , Jan. 13, 2017 ... technology solutions for the homecare industry, including Electronic ... homecare industry expert, Justin Jugs, as Senior Vice ... more than 15 years of homecare experience to ... in developing strategic plans to align Sandata,s suite ...
(Date:1/12/2017)... PORTLAND, Oregon and PUNE, India , January 12, 2017 ... Technology Market: Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology ... CAGR of 19.4% from 2016 to 2022. Continue Reading ... ... ...
(Date:1/6/2017)... Jan. 6, 2017  Privately-held CalciMedica, Inc., announced ... healthy volunteers of a novel calcium release-activated calcium ... pancreatitis. Acute pancreatitis, sudden painful ... disorder, but can be very serious.  In severe cases ... where extended hospital stays, time in the ICU ...
Breaking Biology News(10 mins):